A two-step scoring model incorporating visceral-to-subcutaneous fat ratio and systemic immunoinflammatory index for predicting cytokine release syndrome severity in patients with gastric cancer receiving Claudin18.2-targeted CAR-T cell therapy
Cancer Immunology, Immunotherapy · 09.03.2026 · 75 (4)
DOI: 10.1007/s00262-026-04341-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 09.03.2026. Verfasst von Meng He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and I…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Immunotherapy, Adoptive, Intra-Abdominal Fat, Cytokine Release Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science Foundation of Peking University Cancer Hospital, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Cytokine release syndrome (CRS) greatly impacts survival in patients who undergo chimeric antigen receptor (CAR)-T cell therapy, and the identification of its determinants is still challenging. We analysed the impact of systemic immunoinflammatory index (SII) and body composition parameters derived from CT images on the severity of CRS in 45 patients with advanced gastric cancer treated with CLDN18.2-targeted CAR-T cells. The waist circumference, skeletal muscle index (SMI), skeletal muscle density (SMD), subcutaneous fat area (SFA), visceral fat area (VFA) and VFA-to-SFA ratio (VSR) on baseline CT were automatically segmented and calculated using a deep learning-based tool. The relationship between SII, body composition, and CRS severity was investigated by using ROC analysis, univariate and multivariate binary logistic regression. There were no significant differences in SMI, SMD, SFA and waist circumference between patients with CRS grade 1 and 2. CRS grade 2 patients exhibited significantly higher VSR and SII than patients with CRS grade 1 ( P = 0.003 and 0.012, respectively). ROC analysis showed that the AUCs of VSR and SII for predicting CRS grade were 0.762 (0.620–0.905) and 0.721 (0.563–0.879), respectively. Logistic regression analysis demonstrated that SII > 553 × 10 9 /L and VSR ≥ 0.21 were significantly linked with high grade CRS ( P = 0.035 and 0.014, respectively). We constructed a two-step scoring CRS prediction model based on VSR and SII, and the AUC of this model achieved 0.802 (0.665–0.939) for predicting high-grade CRS in advanced gastric cancer patients receiving CLDN18.2-targeted CAR-T cell therapy, providing a practical tool for early risk stratification and clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, 100142, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, Ch…
- Center for Data Science, Peking University, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Early Drug Development Centre, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142…
- Beijing International Center for Mathematical Research (BICMR), Peking University, Beijing, China.
- Center for Machine Learning Research, Peking University, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Science Foundation of Peking University Cancer Hospital
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Beijing Hospitals Authority Youth Programme
Zitieren
APA
He, M., Liu, L., Chen, Z., Liu, Y., Liu, C., Ma, M., Li, J., Dong, B., Gong, J., Shen, L., Tang, L., & Qi, C. (2026). A two-step scoring model incorporating visceral-to-subcutaneous fat ratio and systemic immunoinflammatory index for predicting cytokine release syndrome severity in patients with gastric cancer receiving Claudin18.2-targeted CAR-T cell therapy. Cancer Immunology, Immunotherapy, 75(4). https://doi.org/10.1007/s00262-026-04341-y
Vancouver
He M, Liu L, Chen Z, Liu Y, Liu C, Ma M, et al. A two-step scoring model incorporating visceral-to-subcutaneous fat ratio and systemic immunoinflammatory index for predicting cytokine release syndrome severity in patients with gastric cancer receiving Claudin18.2-targeted CAR-T cell therapy. Cancer Immunology, Immunotherapy. 2026;75(4). doi:10.1007/s00262-026-04341-y
BibTeX
@article{He2026,
author = {He, Meng and Liu, Lian and Chen, Zifan and Liu, Yiting and Liu, Chang and Ma, Mingyang and Li, Jiarui and Dong, Bin and Gong, Jifang and Shen, Lin and Tang, Lei and Qi, Changsong},
title = {A two-step scoring model incorporating visceral-to-subcutaneous fat ratio and systemic immunoinflammatory index for predicting cytokine release syndrome severity in patients with gastric cancer receiving Claudin18.2-targeted CAR-T cell therapy},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {4},
doi = {10.1007/s00262-026-04341-y}
}
EUVIMED